Quick Answer
MYRIAD GENETICS INC reported Net Income Loss of -$365.90 million for the year ending 2025.
- MYRIAD GENETICS INC showed a decrease of -187.4% in Net Income Loss from 2024 to 2025.
- This data is from MYRIAD GENETICS INC's annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2009 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2016: $32.60 million | Q3 2016: -$700.0 thousand | Q4 2016: $6.10 million | Q1 2017: $2.80 million | Q2 2017: $12.30 million | Q3 2017: $78.80 million | Q4 2017: $30.90 million | Q1 2018: $9.10 million | Q2 2018: $14.50 million | Q3 2018: -$700.0 thousand | Q4 2018: $2.60 million | Q1 2019: $6.90 million | Q2 2019: -$4.20 million | Q3 2019: -$20.60 million | Q4 2019: -$8.30 million | Q1 2020: -$115.20 million | Q2 2020: -$55.40 million | Q3 2020: -$15.20 million | Q1 2021: -$39.50 million | Q2 2021: -$4.70 million | Q3 2021: $24.60 million | Q1 2022: -$20.50 million | Q2 2022: -$14.10 million | Q3 2022: -$35.10 million | Q1 2023: -$54.70 million | Q2 2023: -$116.10 million | Q3 2023: -$61.30 million | Q1 2024: -$26.00 million | Q2 2024: -$36.70 million | Q3 2024: -$22.10 million | Q1 2025: -$100.0 thousand | Q2 2025: -$330.50 million | Q3 2025: -$27.40 million.
- Over the full 18 years of available data (2009 to 2025), MYRIAD GENETICS INC's Net Income Loss has declined by 532.4%.
- Historical annual values: Fiscal year 2025: -$365.90 million | Fiscal year 2024: -$127.30 million | Fiscal year 2023: -$263.30 million | Fiscal year 2022: -$112.00 million | Fiscal year 2021: -$27.20 million | Fiscal year 2020: -$223.60 million | Fiscal year 2020: -$199.50 million | Fiscal year 2019: $4.60 million | Fiscal year 2018: $133.30 million | Fiscal year 2017: $17.40 million | Fiscal year 2016: $117.20 million | Fiscal year 2015: $79.80 million | Fiscal year 2014: $176.20 million | Fiscal year 2013: $147.20 million | Fiscal year 2012: $112.15 million | Fiscal year 2011: $100.71 million | Fiscal year 2010: $152.30 million | Fiscal year 2009: $84.62 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: